AVN-944

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAVN-944
Drug Alias NameVX-944AVN-944
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInosine-5'-monophosphate dehydrogenase 2 inhibitors
TargetsInosine-5'-monophosphate dehydrogenase 2
Therapy Area/IndicationsPancreatic NeoplasmsWaldenstrom MacroglobulinemiaMultiple Myeloma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvalon Pharmaceuticals IncVertex Pharmaceuticals Incorporated
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsWaldenstrom MacroglobulinemiaMultiple Myeloma +[6] 

Other Information

ATC CodeN/A
Related LinksDrugBank